Cocrystal Pharma COCP
NASDAQ COCP
$1.12 +0.00 (+0.00%)
As of: Sep 30, 2026 · 9:58 AM EDT

Cocrystal Pharma (COCP) Convertible Debt (2017 - 2018)

Updated

Cocrystal Pharma (COCP) reported Convertible Debt of $2.04 million for Q1 2018, up 102.5% from the prior quarter.

Analysis

Cocrystal Pharma (COCP) Convertible Debt (2017 - 2018) Analysis & Trends

At the end of FY2017, Cocrystal Pharma posted Convertible Debt of $1.01 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Cocrystal Pharma 16.68 Mn -5.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 2.04 Mn
Dec 31, 2017 1.01 Mn
API Access

Cocrystal Pharma Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=COCP&period=max&api_key=YOUR_API_KEY